Adoptive cellular therapy: A race to the finish line-Reference-Cited by-同舟云学术

Adoptive cellular therapy: A race to the finish line

Published:2015-03-25 Issue:280 Volume:7 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

June Carl H.¹,Riddell Stanley R.²,Schumacher Ton N.³

Affiliation:

1. Center for Cellular Immunotherapies and the Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104-5156, USA.

2. Fred Hutchinson Cancer Research Center, University of Washington, Seattle, WA 98109, USA.

3. Division of Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, Netherlands.

Abstract

Engineered T cells are under development in academic-industry partnerships, accelerating the pace toward widespread availability.

Funder

EU FP7

K. G. Jebsen Center for Cancer Immunotherapy

Publisher

American Association for the Advancement of Science (AAAS)

Subject

General Medicine

Reference55 articles.

1. Quantitative studies on tissue transplantation immunity. II. The origin, strength and duration of actively and adoptively acquired immunity

2. Evaluation of the Therapeutic Potential of Bone Marrow-Derived Myeloid Suppressor Cell (MDSC) Adoptive Transfer in Mouse Models of Autoimmunity and Allograft Rejection

3. IL-10-producing regulatory B cells induced by IL-33 (BregIL-33) effectively attenuate mucosal inflammatory responses in the gut

4. T–cell mediated rejection of gene–modified HIV–specific cytotoxic T lymphocytes in HIV–infected patients

5. J. Scholler T. Brady G. Binder-Scholl W.-T. Hwang G. Plesa K. Hege A. Vogel M. Kalos J. Riley S. Deeks R. Mitsuyasu W. Bernstein N. Aronson B. Levine F. Bushman C. June Decade-long safety and function of retroviral-modified chimeric antigen receptor T cells. Sci. Transl. Med. 4 132Ra153 (2012).

Cited by 320 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Human CD4+CD25+ T cells expressing a chimeric antigen receptor against aberrant superoxide dismutase 1 trigger antigen-specific immunomodulation;Cytotherapy;2024-02

2. Biomaterials to enhance adoptive cell therapy;Nature Reviews Bioengineering;2024-01-26

3. In Situ Reprogramming of Immune Cells Using Synthetic Nanomaterials;Advanced Materials;2024-01-22

4. Transposon-Based Manufacturing of Human CAR-T Cells;Methods in Molecular Biology;2023-12-10

5. Generation of antigen-specific mature T cells from RAG1−/−RAG2−/−B2M−/− stem cells by engineering their microenvironment;Nature Biomedical Engineering;2023-12-07